Kuros Biosciences AG/ CH0325814116 /
10/09/2024 17:13:18 | Chg. +0.21 | Volume | Bid17:20:00 | Ask17:20:00 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
18.10CHF | +1.17% | 4,227 Turnover: 76,230.12 |
-Bid Size: - | -Ask Size: - | 658.84 mill.CHF | - | - |
Assets
2015 IFRS in mill. CHF |
2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 0.0000 | 0.0000 | .6000 | .6000 | .5000 | ||||||
Intangible Assets | 0.0000 | 6.6000 | 33.2000 | 31.1000 | 27.9000 | ||||||
Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Fixed Assets | 0.0000 | 30.4000 | 68.4000 | 66 | 64.6000 | ||||||
Inventories | 0.0000 | 0.0000 | .2000 | .4000 | .5000 | ||||||
Accounts Receivable | - | - | - | - | - | ||||||
Cash and Cash Equivalents | 15.9000 | 12.4000 | 16.7000 | 18.3000 | 20.8000 | ||||||
Current Assets | 16.2000 | 13.4000 | 17.7000 | 19.8000 | 23.3000 | ||||||
Total Assets | 16.2000 | 43.8000 | 86.1000 | 85.8000 | 87.9000 |
Liabilities
2015 IFRS in mill. CHF |
2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 1 | 1.3000 | 1.3000 | 1.6000 | 1.1000 | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | 3.7000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Provisions | .4000 | 2 | 1.7000 | 2.1000 | 2.3000 | ||||||
Liabilities | 5.7000 | 5.4000 | 12.9000 | 9.3000 | 10 | ||||||
Share Capital | 1.3000 | 5.1000 | 8.2000 | 15.1000 | 22.5000 | ||||||
Total Equity | 10.4000 | 38.3000 | 73.1000 | 76.5000 | 77.9000 | ||||||
Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Total liabilities equity | 16.2000 | 43.8000 | 86.1000 | 85.8000 | 87.9000 |
Income Statement
2015 IFRS in mill. CHF |
2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | .2000 | 1.1000 | .5000 | .7000 | 2.6000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | -4.2000 | -21.3000 | -16.2000 | -13.7000 | -11.4000 | ||||||
Interest Income | - | - | - | - | - | ||||||
Income Before Taxes | -5.8000 | -20.3000 | -16.6000 | -13.8000 | -11.8000 | ||||||
Income Taxes | 0.0000 | .6000 | .1000 | 2.1000 | .5000 | ||||||
Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Net Income | -5.8000 | -19.7000 | -16.5000 | -11.7000 | -11.3000 |
Per Share
Cash Flow
2015 IFRS in mill. CHF |
2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -2.6000 | -8.9000 | -10.7000 | -12.8000 | -10.8000 | ||||||
Cash Flow from Investing Activities | 0.0000 | 1.8000 | -.9000 | -.7000 | -.1000 | ||||||
Cash Flow from Financing | 17 | 3.5000 | 16 | 15 | 13.1000 | ||||||
Decrease / Increase in Cash | 14.4000 | -3.6000 | 4.4000 | 1.5000 | 2.2000 | ||||||
Employees | 4 | 16 | 28 | 9 | 6 |